In January 2013, Medical device companies began paying a 2.3% excise tax on U.S. Sales in order to pay for the Patient Protection and Affordable Care Act.

The levy is expected to generate some $30 billion over the next 10 years.

MassDevice.com is tracking the tally paid by several medical device companies, based on quarterly earnings report for the first quarter of 2013. We will update the list as more companies returns file in.

Tallies based on companies with Q1 earnings ended on March 31, 2013

• AtriCure (NSDQ:ATRC) – $120,000
• Boston Scientific (NYSE:BSX) – $17 million
• Becton Dickinson & Co. (NYSE:BDX) – $14 million
• Covidien (NYSE:COV) – $18 million
• C.R. Bard (NYSE:BCR) – $8 million
• Hologic (NSDQ:HOLX) – $6.5 million
• Intuitive Surgical (NSDQ:ISRG) – $6.5 million
• Masimo (NSDQ:MASI)- $1.8 million
• NxStage Medical (NSDQ:NXTM) – $3 million
• Spectranetics (NSDQ:SPNC) – $500,000
• Stryker (NYSE:SYK) – $23 million
• Volcano (NSDQ:VOLC) – $634,000